NES
FLNA

New England Securities’s Filana Therapeutics FLNA Stock Holding History

New England Securities’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$2K Hold
171
– – ﹤0.01% 1494
2014
Q3 		$5K Hold
171
– – ﹤0.01% 1284
2014
Q2 		$7K Hold
171
– – ﹤0.01% 1221
2014
Q1 		$7K Hold
171
– – ﹤0.01% 1175
2013
Q4 		$6K Hold
171
– – ﹤0.01% 1173
2013
Q3 		$3K Sell
171
-86
-33% -$1.5K ﹤0.01% 1339
2013
Q2 		$4K Buy
+257
New +$5.43K ﹤0.01% 1116

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

New England Securities's FLNA Position: Q4 2014 in Review

New England Securities held its Filana Therapeutics (FLNA) position steady in Q4 2014 at 171 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1494.

New England Securities first reported a position in FLNA in Q2 2013 and has held it in 7 quarters since. The position peaked at $7K in Q2 2014. 66 funds tracked by Wall St. Rank hold FLNA as of Q4 2014.

  • New England Securities held 171 shares of Filana Therapeutics worth $2K as of Q4 2014.
  • New England Securities left its Filana Therapeutics share count unchanged in Q4 2014.
  • Filana Therapeutics made up ﹤0.01% of New England Securities's portfolio in Q4 2014, its #1494 holding.
  • New England Securities first reported a position in Filana Therapeutics in Q2 2013 and has held it in 7 quarters since.
  • New England Securities's Filana Therapeutics position peaked at $7K in Q2 2014.
  • 66 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.